2025 Novel radiotherapy target definition using AI-driven predictions of glioblastoma recurrence from metabolic and diffusion MRI.
2025 Tele-cognitive rehabilitation for adult lower-grade glioma: An interim prospective pilot feasibility study.
2024 The University of California San Francisco Adult Longitudinal Post-Treatment Diffuse Glioma (UCSF-ALPTDG) MRI Dataset.
2024 Improving the Generalizability of Deep Learning for T2-Lesion Segmentation of Gliomas in the Post-Treatment Setting.
2024 Understanding the association between fatigue and neurocognitive functioning in patients with glioma: A cross-sectional multinational study.
2023 PNOC015: Repeated convection enhanced delivery (CED) of MTX110 (aqueous panobinostat) in children with newly diagnosed diffuse intrinsic pontine glioma (DIPG).
2023 Evaluation of major depressive disorder using 7 Tesla phase sensitive neuroimaging before and after mindfulness-based cognitive therapy.
2023 Interactive Effects of Molecular, Therapeutic, and Patient Factors on Outcome of Diffuse Low-Grade Glioma.
2022 Longitudinal MR spectroscopy to detect progression in patients with lower-grade glioma in the surveillance phase.
2022 Upfront biology-guided therapy in diffuse intrinsic pontine glioma: therapeutic, molecular, and biomarker outcomes from PNOC003.